1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. BIOCON LTD.

Biocon Ltd.

NSE: BIOCON | BSE: 532523

Slowing Down Stock
Download real time

316.55 10.25 (3.35%)

3.3M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
12S
9W
5O
0T
14,761.8

Operating Revenue TTM

Market Leader
804.3

Net profit TTM

Market Leader
5.4

Net Profit Margin TTM %

1

Operating Revenue growth TTM %

Above industry Median
-33

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
US FDA Approval
Biocon receives USFDA approval for Jobevne, used in cancer treatment, with a market size of ~$2 bn See details

Biocon Ltd. quarterly, annual results, revenue, profit, P&L, Balance Sheet, Cash Flow, Annual Reports, Margins - 15 Years history